Ketohexokinase
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
{{STRUCTURE_3nbv| PDB=3nbv | SIZE=400| SCENE= |right|CAPTION=Ketohexokinase dimer complex with fructose and AMPPNP (stick model) [[3nbv]] }} | {{STRUCTURE_3nbv| PDB=3nbv | SIZE=400| SCENE= |right|CAPTION=Ketohexokinase dimer complex with fructose and AMPPNP (stick model) [[3nbv]] }} | ||
| + | <StructureSection load='2q92' size='350' side='right' caption='Human α-defensin 1 (PDB entry [[2pm4]])' scene=''> | ||
| + | == Function == | ||
| + | '''Ketohexokinase''' (KHK) also known as hepatic fructokinase catalyzes the phosphorylation of fructose to fructose-1-phosphate using ATP as phosphate source in the liver. The HKH gene is spliced to HKH-A and the more active HKH-C. KHK acts in the first step of fructose metabolism<ref>PMID:2996495</ref>. | ||
| - | + | == Disease == | |
| - | + | HKH deficiency causes the essential fructosuria disorder<ref>PMID:12941785</ref>. | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| + | == Structural highlights == | ||
| + | <ref>PMID:8528769</ref> | ||
| + | </StructureSection> | ||
==3D structuresm of ketohexokinase== | ==3D structuresm of ketohexokinase== | ||
| Line 14: | Line 16: | ||
[[3nbw]] – hKHK + pyrazole derivative<br /> | [[3nbw]] – hKHK + pyrazole derivative<br /> | ||
[[3nc2]], [[3nc9]], [[3nca]], [[3ro4]], [[3q92]], [[3qa2]], [[3qai]] – hKHK + inhibitor | [[3nc2]], [[3nc9]], [[3nca]], [[3ro4]], [[3q92]], [[3qa2]], [[3qai]] – hKHK + inhibitor | ||
| - | + | == References == | |
| + | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Revision as of 09:30, 6 April 2016
| |||||||||||
3D structuresm of ketohexokinase
2hlz, 2hqq, 3b3l – hKHK – human
2hw1, 3nbv – hKHK + AMPPNP + fructose
3nbw – hKHK + pyrazole derivative
3nc2, 3nc9, 3nca, 3ro4, 3q92, 3qa2, 3qai – hKHK + inhibitor
References
- ↑ Bais R, James HM, Rofe AM, Conyers RA. The purification and properties of human liver ketohexokinase. A role for ketohexokinase and fructose-bisphosphate aldolase in the metabolic production of oxalate from xylitol. Biochem J. 1985 Aug 15;230(1):53-60. PMID:2996495
- ↑ Asipu A, Hayward BE, O'Reilly J, Bonthron DT. Properties of normal and mutant recombinant human ketohexokinases and implications for the pathogenesis of essential fructosuria. Diabetes. 2003 Sep;52(9):2426-32. PMID:12941785
- ↑ White SH, Wimley WC, Selsted ME. Structure, function, and membrane integration of defensins. Curr Opin Struct Biol. 1995 Aug;5(4):521-7. PMID:8528769
